The growth of Viagra and its effect on the medicinal landscape presents a complicated question for shareholders. While the first sales data were impressive, the intellectual property has expired, leading to a wave of https://donnasfbi586928.blogofchange.com/42047683/sildenafil-and-big-pharma-a-risky-investment